Early discontinuation of DTG/ABC/3TC and BIC/TAF/FTC single-tablet regimens: a real-life multicenter cohort study

Early discontinuation of DTG/ABC/3TC and BIC/TAF/FTC single-tablet regimens: a real-life multicenter cohort study

Background: Data regarding the efficacy and tolerability of DTG/ABC/3TC/and BIC/TAF/FTC in switching strategies are still scarce. The rates and reasons of early discontinuation within 24 weeks from the switch to dolutegravir (DTG) or bictegravir (BIC) single-tablet regimens (STRs) were compared. Met...

Full description

Bibliographic Details
Main Authors: Filippo Lagi, Annarita Botta, Arturo Ciccullo, Chiara Picarelli, Massimiliano Fabbiani, Simona di Giambenedetto, Vanni Borghi, Cristina Mussini, Alessandro Bartoloni, Gaetana Sterrantino
Format: Article
Language:English
Published: Taylor & Francis Group 2021-09-01
Series:HIV Research & Clinical Practice
Subjects:
dtg/abc/3tc
bic/taf/ftc
str
early discontinuation
cohort study
switch
Online Access:http://dx.doi.org/10.1080/25787489.2021.1965757

Internet

http://dx.doi.org/10.1080/25787489.2021.1965757

Similar Items